National Institutes of Health Center for Translational Therapeutics
NCTT is now part of the NIH National Center for Advancing Translational Sciences (NCATS). Content on this site will move to NCATS.NIH.GOV

RNAi

Overview

RNAi readoutGene silencing through RNAi has emerged as a powerful tool for understanding gene function. Over the past several years, high-throughput RNAi screens have illuminated a wide variety of biology ranging from genes that affect the activity of therapeutic agents to elucidating novel components of signaling pathways. The National Institutes of Health (NIH) has recently established a state-of-the-art RNAi screening facility that is now soliciting proposals from any intramural researcher. This facility assists with all stages of projects beginning with assay development through genome-wide siRNA screens, informatics/pathway analysis, and rigorous follow-up. Genome-wide siRNA screens for both human and mouse are available. Also routinely included in screens are miRNA mimic and inhibitor libraries.

See all related projects for the RNAi Program

For more information, visit RNAi
Interested researchers should contact:

Scott Martin, Ph.D.
Phone: 301-827-9714
E-mail: martinsc@mail.nih.gov

RNAi Staff


Last Updated: August 19, 2011